2.209 Long-term double-blind, placebo-controlled evaluation of the safety and efficacy of safinamide as an add-on to stable dopamine agonist therapy in patients with Parkinson's disease

2007 ◽  
Vol 13 ◽  
pp. S99-S100 ◽  
Author(s):  
R. Anand ◽  
V. Lucini ◽  
R. Guiliani ◽  
S. Rossetti
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Agonist Therapy ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Dopamine Agonist Therapy ◽  
Controlled Evaluation

scholarly journals In a Rush to Decide: Deep Brain Stimulation and Dopamine Agonist Therapy in Parkinson's Disease

2014 ◽  
Vol 4 (4) ◽  
pp. 579-583 ◽  
Author(s):  
Atbin Djamshidian ◽  
Sean S. O'Sullivan ◽  
Alessandro Tomassini ◽  
Thomas Foltynie ◽  
Patricia Limousin ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Deep Brain Stimulation ◽  
Dopamine Agonist ◽  
Brain Stimulation ◽  
Agonist Therapy ◽  
Dopamine Agonist Therapy ◽  
Deep Brain

Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study

2014 ◽  
Vol 85 (8) ◽  
pp. 840-844 ◽  
Author(s):  
P. J. Garcia-Ruiz ◽  
J. C. Martinez Castrillo ◽  
A. Alonso-Canovas ◽  
A. Herranz Barcenas ◽  
L. Vela ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Multicentre Study ◽  
Dopamine Agonist ◽  
Impulse Control ◽  
Impulse Control Disorder ◽  
Agonist Therapy ◽  
Dopamine Agonist Therapy
Sign in / Sign up

Export Citation Format

Share Document